Abdelnaby Khalyfa1, David Gozal2, Juan F Masa3,4, José Maria Marin5,6, Zhuanghong Qiao2, Jaime Corral4,7, Mónica González8, Sergi Marti4,9, Leila Kheirandish-Gozal2, Carlos Egea7, M-Ángeles Sánchez-Quiroga10, Francisco J Gómez de Terreros3,4, F Javier Barca11. 1. Section of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA. akhalyfa@uchicago.edu. 2. Section of Pediatric Sleep Medicine, Department of Pediatrics, Biological Sciences Division, Pritzker School of Medicine, The University of Chicago, Chicago, IL, USA. 3. San Pedro de Alcántara Hospital, Cáceres, Spain. 4. Centro de Investigación Biomédica en Red de enfermedades respiratorias (CIBERES), Madrid, Spain. 5. Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza, Spain. 6. CIBER Enfermedades Respiratorias (CIBERES), Zaragoza, Spain. 7. Sleep Unit and Respiratory Department, Alava University Hospital IRB, Vitoria, Spain. 8. Valdecilla Hospital, Santander, Spain. 9. Valld'Hebron Hospital, Barcelona, Spain. 10. Virgen del Puerto Hospital, Plasencia, Spain. 11. Extremadura University, Caceres, Spain.
Abstract
BACKGROUND:Sleep-disordered-breathing (SDB), which is characterized by chronic intermittent hypoxia (IH) and sleep fragmentation (SF), is a prevalent condition that promotes metabolic dysfunction, particularly among patients suffering from obstructive hypoventilation syndrome (OHS). Exosomes are generated ubiquitously, are readily present in the circulation, and their cargo may exert substantial functional cellular alterations in both physiological and pathological conditions. However, the effects of plasma exosomes on adipocyte metabolism in patients with OHS or in mice subjected to IH or SF mimicking SDB are unclear. METHODS: Exosomes from fasting morning plasma samples from obese adults with polysomnographically-confirmed OSA before and after 3 months of adherent CPAP therapy were assayed. In addition, C57BL/6 mice were randomly assigned to (1) sleep control (SC), (2) sleep fragmentation (SF), and (3) intermittent hypoxia (HI) for 6 weeks, and plasma exosomes were isolated. Equivalent exosome amounts were added to differentiated adipocytes in culture, after which insulin sensitivity was assessed using 0 nM and 5 nM insulin-induced pAKT/AKT expression changes by western blotting. RESULTS: When plasma exosomes were co-cultured and internalized by human naive adipocytes, significant reductions emerged in Akt phosphorylation responses to insulin when compared to exosomes obtained after 24 months of adherent CPAP treatment (n = 24; p < 0.001), while no such changes occur in untreated patients (n = 8). In addition, OHS exosomes induced significant increases in adipocyte lipolysis that were attenuated after CPAP, but did not alter pre-adipocyte differentiation. Similarly, exosomes from SF- and IH-exposed mice induced attenuated p-AKT/total AKT responses to exogenous insulin and increased glycerol content in naive murine adipocytes, without altering pre-adipocyte differentiation. CONCLUSIONS: Using in vitro adipocyte-based functional reporter assays, alterations in plasma exosomal cargo occur in SDB, and appear to contribute to adipocyte metabolic dysfunction. Further exploration of exosomal miRNA signatures in either human subjects or animal models and their putative organ and cell targets appears warranted.
RCT Entities:
BACKGROUND:Sleep-disordered-breathing (SDB), which is characterized by chronic intermittent hypoxia (IH) and sleep fragmentation (SF), is a prevalent condition that promotes metabolic dysfunction, particularly among patients suffering from obstructive hypoventilation syndrome (OHS). Exosomes are generated ubiquitously, are readily present in the circulation, and their cargo may exert substantial functional cellular alterations in both physiological and pathological conditions. However, the effects of plasma exosomes on adipocyte metabolism in patients with OHS or in mice subjected to IH or SF mimicking SDB are unclear. METHODS: Exosomes from fasting morning plasma samples from obese adults with polysomnographically-confirmed OSA before and after 3 months of adherent CPAP therapy were assayed. In addition, C57BL/6 mice were randomly assigned to (1) sleep control (SC), (2) sleep fragmentation (SF), and (3) intermittent hypoxia (HI) for 6 weeks, and plasma exosomes were isolated. Equivalent exosome amounts were added to differentiated adipocytes in culture, after which insulin sensitivity was assessed using 0 nM and 5 nM insulin-induced pAKT/AKT expression changes by western blotting. RESULTS: When plasma exosomes were co-cultured and internalized by human naive adipocytes, significant reductions emerged in Akt phosphorylation responses to insulin when compared to exosomes obtained after 24 months of adherent CPAP treatment (n = 24; p < 0.001), while no such changes occur in untreated patients (n = 8). In addition, OHS exosomes induced significant increases in adipocyte lipolysis that were attenuated after CPAP, but did not alter pre-adipocyte differentiation. Similarly, exosomes from SF- and IH-exposed mice induced attenuated p-AKT/total AKT responses to exogenous insulin and increased glycerol content in naive murine adipocytes, without altering pre-adipocyte differentiation. CONCLUSIONS: Using in vitro adipocyte-based functional reporter assays, alterations in plasma exosomal cargo occur in SDB, and appear to contribute to adipocyte metabolic dysfunction. Further exploration of exosomal miRNA signatures in either human subjects or animal models and their putative organ and cell targets appears warranted.
Authors: Deepti Nair; Shelley X L Zhang; Vijay Ramesh; Fahed Hakim; Navita Kaushal; Yang Wang; David Gozal Journal: Am J Respir Crit Care Med Date: 2011-08-25 Impact factor: 21.405
Authors: Monica J Hubal; Evan P Nadler; Sarah C Ferrante; Matthew D Barberio; Jung-Hyuk Suh; Justin Wang; G Lynis Dohm; Walter J Pories; Michelle Mietus-Snyder; Robert J Freishtat Journal: Obesity (Silver Spring) Date: 2016-11-24 Impact factor: 5.002
Authors: Olalla Castro-Añón; Luis A Pérez de Llano; Sandra De la Fuente Sánchez; Rafael Golpe; Lidia Méndez Marote; Julián Castro-Castro; Arturo González Quintela Journal: PLoS One Date: 2015-02-11 Impact factor: 3.240
Authors: Valeriy A Poroyko; Alba Carreras; Abdelnaby Khalyfa; Ahamed A Khalyfa; Vanessa Leone; Eduard Peris; Isaac Almendros; Alex Gileles-Hillel; Zhuanhong Qiao; Nathaniel Hubert; Ramon Farré; Eugene B Chang; David Gozal Journal: Sci Rep Date: 2016-10-14 Impact factor: 4.379
Authors: Javier Lázaro; Paloma Clavería; Carmen Cabrejas; José Fernando; Berta Daga; Beatriz Ordoñez; Silvia Segura; David Sanz-Rubio; José M Marín Journal: Respir Res Date: 2020-02-04
Authors: Abdelnaby Khalyfa; Shobhan Gaddameedhi; Elena Crooks; Chunling Zhang; Yan Li; Zhuanhong Qiao; Wojciech Trzepizur; Steve A Kay; Jorge Andrade; Brieann C Satterfield; Devon A Hansen; Leila Kheirandish-Gozal; Hans P A Van Dongen; David Gozal Journal: Int J Mol Sci Date: 2020-09-03 Impact factor: 5.923
Authors: Anna Brzecka; Karolina Sarul; Tomasz Dyła; Marco Avila-Rodriguez; Ricardo Cabezas-Perez; Vladimir N Chubarev; Nina N Minyaeva; Sergey G Klochkov; Margarita E Neganova; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Vadim V Tarasov; Gjumrakch Aliev Journal: Curr Genomics Date: 2020-09 Impact factor: 2.236